Inventor · disambiguated record
Steven A. Carr
Also filed as: CARR STEVEN · CARR STEVEN A
8 granted patents·9 pending applications·9 citations·filing 2011–2024
79Inventor score
Files withBROAD INST INC10DANA FARBER CANCER INST INC2MASSACHUSETTS INST TECHNOLOGY2BAYLOR COLLEGE MEDICINE1GERSZTEN ROBERT1
Top patents by PatentIndex Score
17 records- 0183US10334829B2IMiD screening methods IMiD-sensitive cells with mutant CRBNBROAD INST INC·Filed 2018·Granted Jul 2, 2019·2 cites·9 claims
- 0282US9974289B2Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereofBROAD INST INC·Filed 2016·Granted May 22, 2018·2 cites·14 claims
- 0378US10024860B2Cancer-related extracellular matrix signatures and related methods and productsMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jul 17, 2018·2 cites·6 claims
- 0474US9526800B2Cancer-related extracellular matrix signatures and related methods and productsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Dec 27, 2016·2 cites·8 claims
- 0568US11785925B2Disease biomarkers and treatment methods related theretoBROAD INST INC·Filed 2019·Granted Oct 17, 2023·0 cites·16 claims
- 0662US2025189529A1High risk biomarkers for myeloma precursor disease progression and methods of use thereofDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 0759US2016282354A1Compositions and methods for selecting a treatment for b-cell neoplasiasBROAD INST INC·Filed 2014·Application pending·0 cites
- 0857US9702886B2Methods and devices for tuberculosis diagnosis using biomarker profilesBROAD INST INC·Filed 2013·Granted Jul 11, 2017·1 cites·21 claims
- 0953US12419948B2Immunogenic compositions and use thereofBROAD INST INC·Filed 2021·Granted Sep 23, 2025·0 cites·29 claims
- 1048US2021322405A1Compositions and methods for treating cancerUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1147US2022326241A1Proteogenomic methods for diagnosing cancerBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1247US2022062394A1Methods for identifying neoantigensBROAD INST INC·Filed 2019·Application pending·0 cites
- 1346US2023248814A1Compositions and methods for treating merkel cell carcinoma (mcc) using hla class i specific epitopesBROAD INST INC·Filed 2021·Application pending·0 cites
- 1445US12188059B2Proximity-dependent biotinylation and uses thereofBROAD INST INC·Filed 2017·Granted Jan 7, 2025·0 cites·26 claims
- 1542US2021382068A1Hla single allele linesDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1636US2019346442A1Improved hla epitope predictionBROAD INST INC·Filed 2017·Application pending·0 cites
- 1730US2014045714A1Novel Biomarkers For Cardiovascular InjuryGERSZTEN ROBERT·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →